Correlation between tru cut biopsy and final pathology in soft tissue sarcomas

: MOJ Women's Health
: Maria Augusta Velasco Basantes, Juan Carlos Merida, Alvaro Forno Noriega

Abstract

Introduction: There are 50 to 60 different subtypes of soft tissue sarcomas, with a mean age of presentation in adults between 40 and 60 years and a 5-year survival rate of 64.7%. The main symptom is the appearance of a lump or tumor of variable growth, predominantly soft tissue sarcomas affecting the extremities. The diagnostic method involves taking a sample through biopsy, which is one of the main causes of recurrence. Depending on the type of biopsy used, it can alter the disease’s behavior and prognosis. Therefore, the tru-cut biopsy, being an economical, minimally invasive method with rapid recovery and minimal complications, allows for the early establishment of therapeutic strategies, making it the method of choice.

Materials and methods: Retrospective and descriptive study of patients with histological diagnosis of soft tissue sarcoma from January 2018 to December 2020 at the Institute of Cancerology and Hospital Dr. Bernardo del Valle S. INCAN Guatemala City - Guatemala. The Tru cut biopsy was compared vs. the final pathology.

Results: In 16 cases (38 %) the use of immunohistochemistry was necessary to confirm the diagnosis, the most affected age was between 49 - 68 years (40.4 %), the main histological type was pleomorphic sarcoma (23.8 %), the extremities were the most affected (38.1%) and tomography was the study that was most used (83.3%).

Keywords

sarcoma, immunohistochemistry, biopsy

Correlation between tru cut biopsy and final pathology in soft tissue sarcomas

Abstract

Keywords

Quick Links

Related Journals